M. Chevallier

发表

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

X. Causse, H. Godinot, M. Chevallier, 1991, Gastroenterology.

Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver

M. Chevallier, J. Behr, H. Blum, 2001, Gene Therapy.

The isolated perfused porcine liver: assessment of viability during and after six hours of perfusion

M. Chevallier, M. Adham, S. Peyrol, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients].

M. Chevallier, F. Zoulim, C. Trépo, 2003, Gastroenterologie clinique et biologique.

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

M. Chevallier, F. Zoulim, C. Trépo, 2003, Gut.

Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus.

M. Chevallier, I. Chemin, C. Trépo, 2002, The Journal of general virology.

Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus.

M. Chevallier, I. Chemin, C. Trépo, 2002 .

Clinical consequences of hepatitis C virus infection

M. Chevallier, F. Zoulim, C. Trépo, 2003, Reviews in medical virology.

Infection Woodchuck Model of Hepatitis B Virus Delivery of Gamma Interferon in the Emtricitabine with Adenovirus-Mediated Effect of a Combination of Clevudine and

M. Chevallier, F. Zoulim, S. Guerret, 2004 .

Effect of a Combination of Clevudine and Emtricitabine with Adenovirus-Mediated Delivery of Gamma Interferon in the Woodchuck Model of Hepatitis B Virus Infection

M. Chevallier, F. Zoulim, S. Guerret, 2004, Antimicrobial Agents and Chemotherapy.

Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus

M. Chevallier, F. Zoulim, S. Guerret, 2001, Antimicrobial Agents and Chemotherapy.

Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo.

M. Chevallier, P. Couvreur, E. Soma, 2005, Journal of hepatology.

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology.

M. Chevallier, F. Zoulim, I. Chemin, 2001, Journal of hepatology.

Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

Yung-chi Cheng, M. Chevallier, F. Zoulim, 2000, Antimicrobial Agents and Chemotherapy.

Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.

M. Chevallier, F. Zoulim, C. Trépo, 2005, Journal of hepatology.

The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis.

S. Ricard-Blum, M. Chevallier, P. Chossegros, 1996, Clinica chimica acta; international journal of clinical chemistry.

Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.

M. Chevallier, P. Chossegros, D. Ouzan, 1986, Journal of hepatology.

Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.

M. Chevallier, F. Zoulim, C. Trépo, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In situ detection of human cytomegalovirus DNA in gastrointestinal biopsies from AIDS patients by means of various PCR-derived methods.

M. Chevallier, L. Cotte, E. Drouet, 1996, Journal of virological methods.

Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.

M. Chevallier, T. Fontanges, C. Trépo, 2008, Gastroenterologie clinique et biologique.

Peginterferon alpha‐2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha‐2b

D. Dhumeaux, M. Chevallier, A. Tran, 2006, Journal of viral hepatitis.

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

M. Chevallier, C. Trépo, C. Ducerf, 1997, Hepatology.

Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys

N. Tordo, M. Chevallier, H. Contamin, 2009, Journal of Virology.

Cell populations in the lesion of human cutaneous leishmaniasis: A light microscopical, immunohistochemical and ultrastructural study

M. Chevallier, J. Dedet, J. Grimaud, 2005, Virchows Archiv A.

Co-infection by hepatitis B virus and hepatitis C virus in renal transplantation: morbidity and mortality in 1098 patients.

M. Chevallier, P. Chossegros, C. Pouteil‐Noble, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The isolated perfused porcine liver: assessment of viability during and after six hours of perfusion

M. Chevallier, M. Adham, S. Peyrol, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis.

S. Ricard-Blum, M. Chevallier, D. Vuitton, 2001, Journal of hepatology.

Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome.

M. Chevallier, J. Dumortier, J. Scoazec, 2001, Scandinavian journal of gastroenterology.

Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families

P. Potier, M. Chevallier, J. Dumortier, 1999, Gut.

Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.

M. Chevallier, B. Napoléon, F. Berger, 1991, Gut.

Elastin in human, baboon, and mouse liver: An immunohistochemical and immunoelectron microscopic study

M. Chevallier, S. Guerret, S. Peyrol, 1990, The Anatomical record.

Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice.

M. Buendia, M. Chevallier, C. Trépo, 2001, Journal of hepatology.

Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study.

M. Chevallier, J. Grimaud, S. Mahfouz, 1987, Cellular and molecular biology.

Elastin in alcoholic liver disease. An immunohistochemical and immunoelectron microscopic study.

M. Chevallier, S. Guerret, D. Hartmann, 1990, Pathology, research and practice.

Enhanced duck hepatitis B virus gene expression following aflatoxin B exposure

M. Chevallier, C. Wild, C. Borel, 1999, Hepatology.

Characterization of the Antiviral Effect of 2 9 ,3 9 -Dideoxy-2 9 , 3 9 -Didehydro- b - L -5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

M. Chevallier, F. Zoulim, C. Trépo, 1999 .

The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.

M. Chevallier, C. Wild, J. Cadet, 2001, Cancer detection and prevention.

Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation

A. Niveleau, M. Chevallier, A. Boibieux, 1995, Journal of clinical microbiology.

Recurrence of hepatocellular carcinoma as a mixed hepatoblastoma after liver transplantation

M. Chevallier, J. Dumortier, J. Scoazec, 1999, Gut.

Inhibitory Effect of 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyl-Uracil on Duck Hepatitis B Virus Replication

M. Chevallier, F. Zoulim, C. Borel, 1998, Antimicrobial Agents and Chemotherapy.

Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.

C. Gibbs, M. Chevallier, F. Zoulim, 2003, Journal of hepatology.

Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection.

M. Chevallier, P. Chossegros, D. Ouzan, 1986, Journal of hepatology.

In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes

M. Chevallier, F. Zoulim, S. Guerret, 2013, Journal of viral hepatitis.

DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.

M. Chevallier, F. Zoulim, C. Trépo, 2008, The Journal of general virology.

Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa‐2b versus no treatment

P. Marcellin, M. Chevallier, D. Valla, 1999, Hepatology.

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

P. Couzigou, M. Chevallier, P. Bedossa, 1995, The New England journal of medicine.

Interferon‐α2b therapy reduces liver fibrosis in chronic non‐A, non‐B hepatitis: A quantitative histological evaluation

X. Causse, M. Chevallier, P. Chossegros, 1993, Hepatology.

Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.

X. Causse, M. Chevallier, P. Chossegros, 1991, Journal of hepatology.

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.

L. Stuyver, M. Chevallier, F. Zoulim, 2000, Journal of hepatology.

Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy

M. Chevallier, J. Lucet, F. Bruneel, 1994, Journal of internal medicine.

Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon‐α

M. Chevallier, F. Zoulim, C. Trépo, 1998, Journal of viral hepatitis.

Occult HBV infection may represent a major risk factor of non‐response to antiviral therapy of chronic hepatitis C

M. Chevallier, F. Zoulim, O. Guillaud, 2007, Journal of medical virology.

A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies

M. Chevallier, P. Chossegros, S. Guerret, 1994, Hepatology.

Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients

M. Chevallier, P. Chossegros, F. Zoulim, 1998, Journal of viral hepatitis.

Progression to cirrhosis in hepatitis C patients: an age‐dependent process

N. Voirin, M. Chevallier, H. Tillmann, 2007, Liver international : official journal of the International Association for the Study of the Liver.

[Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].

P. Marcellin, M. Chevallier, P. Chossegros, 1987, Gastroenterologie clinique et biologique.

The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.

P. Vanhems, M. Chevallier, F. Zoulim, 2011, Journal of hepatology.

Long‐term administration of interferon‐α in non‐responder patients with chronic hepatitis C: follow‐up of liver fibrosis over 5 years

M. Chevallier, P. Chossegros, A. Desmoulière, 1999, Journal of viral hepatitis.

Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV‐coinfected patients

M. Chevallier, M. Chevallier, F. Zoulim, 2011, Journal of viral hepatitis.

Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice

M. Chevallier, C. Trépo, S. Guerret, 2003, Oncogene.

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand

P. Hainaut, S. Sangrajrang, M. Chevallier, 2011, Hepatitis research and treatment.

Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas

M. Chevallier, J. Forteza, G. Morel, 2000, Endocrine.

Matrix remodelling and fibroblast phenotype in early lesions of human cutaneous leishmaniasis.

M. Chevallier, J. Dedet, S. Guerret, 1991, Pathology, research and practice.

Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

M. Manns, D. Franchimont, J. Sninsky, 2011, Hepatology.

Liver fibrosis in unisexual murine Schistosomiasis: quantitative study and morphological changes in mice with chronic infection.

M. Chevallier, S. Guerret, J. Grimaud, 1998, Cellular and molecular biology.

Diagnosis of Xp11 translocation renal cell carcinomas in adult patients under 50 years: interest and pitfalls of automated immunohistochemical detection of TFE3 protein.

M. Chevallier, M. Colombel, J. Scoazec, 2013, Pathology, research and practice.

Morphometry of terminal hepatic veins

M. Chevallier, J. Grimaud, L. Porto, 2004, Virchows Archiv A.

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma.

M. Chevallier, F. Zoulim, Miran Kim, 2011, Journal of hepatology.

Expression of HLA antigens and T cell infiltrates in chronic viral hepatitis. A comparison of biopsy and fine-needle aspiration findings.

M. Chevallier, P. Chossegros, E. Krawitt, 1991, Journal of hepatology.

Non‐invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study

M. Chevallier, P. Sogni, J. Zarski, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Small Nodule Detection in Cirrhotic Livers: Evaluation with US, Spiral CT, and MRI and Correlation with Pathologic Examination of Explanted Liver

V. Vilgrain, P. Douek, M. Chevallier, 2001, Journal of computer assisted tomography.

Human extrahepatic biliary atresia: portal connective tissue activation related to ductular proliferation.

M. Chevallier, L. A. D. de Freitas, J. Grimaud, 2008, Liver.

Requirements for physiological perfusion of isolated liver with autologous blood.

M. Chevallier, M. Raccurt, M. Adham, 1996, Transplantation proceedings.

Use of serum biomarkers in staging of canine hepatic fibrosis

M. Chevallier, P. Lecoindre, A. Pagnon, 2019, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Histological scoring of fibrosis and activity in HIV–chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides

M. Chevallier, D. Wendum, J. Molina, 2009, Journal of Clinical Pathology.

Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis

V. de Lédinghen, M. Chevallier, S. Pol, 2004, European journal of gastroenterology & hepatology.

[Autoimmunization induced by interferon alpha therapy in chronic hepatitis C].

M. Chevallier, F. Zoulim, C. Trépo, 2004, Gastroenterologie clinique et biologique.

Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.

M. Chevallier, M. Adham, C. Ducerf, 1998, Transplantation proceedings.

More Reasons for Hope in the Therapy of Chronic Hepatitis C

X. Causse, M. Chevallier, N. Manabe, 1994 .

A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies

M. Chevallier, P. Chossegros, S. Guerret, 1994, Hepatology.

O.123 Pattern of HBV/HCV infection and TP53/beta-catenin mutations in HCC cases from Thailand

P. Hainaut, M. Chevallier, S. Villar, 2006 .

Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV‐coinfected patients

M. Chevallier, M. Trabaud, J. Bottero, 2011, Journal of viral hepatitis.

Morphological aspects of early and late collagen degradation in granulation tissue.

M. Chevallier, L. A. D. de Freitas, J. Grimaud, 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Immunohistochemical micromethods for the measurement of specific collagen types in human liver biopsies.

M. Chevallier, S. Guerret, M. Rojkind, 1988, Collagen and related research.

M. Chevallier, F. Zoulim, P. Pradat, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma.

M. Chevallier, F. Zoulim, Miran Kim, 2011, Journal of hepatology.